Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current Assets:
Cash	$ 56,899	$ 20,033
Accounts receivable	22,000	6,000
Prepaid expenses	15,751	11,460
Total Assets	94,650	37,493
Current Liabilities:
Accounts payable and accrued expenses	155,019	101,131
Total Current Liabilities	155,019	101,131
Long Term Liabilities
Convertible notes payable, related parties, net of issuance costs	401,186	306,254
Total Long Term Liabilities	401,186	306,254
Total Liabilities	556,205	407,385
Stockholders' Deficit
Preferred stock: 50,000,000 shares authorized, 0 shares issued at March 31, 2020 and December 31, 2019	0	0
Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 40,300,106 common shares issued and 31,750,106 shares outstanding at December 31, 2019 and December 31, 2018, respectively	3,981	3,981
Additional paid-in capital	12,689,980	12,689,980
Treasury stock, 8,550,000 shares at cost	(491,139)	(491,139)
Accumulated deficit	(12,664,377)	(12,572,714)
Total Stockholders' Deficit	(461,555)	(369,892)
Total Liabilities and Stockholders' Deficit	$ 94,650	$ 37,493